EUVIMEDEUVIMED entdecken
Crossref

Challenging Breast Cancer Through Novel sulfonamide–pyridine Hybrids: design, synthesis, Carbonic Anhydrase IX Inhibition and Induction of Apoptosis

Nashwa H Zaher iD, Reham Mm Elhazek, Ahmed E Gouda, Amira Khalil, Marwa G Elgazzar

Future Medicinal Chemistry · 2023

DOI: 10.4155/fmc-2022-0197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2023. Verfasst von Nashwa H Zaher und 4 weiteren Autor:innen. Beteiligte Einrichtung: Drug Radiation Research, National Center for Radiation Research & Technology (NCRRT), Egyptian Atomic Energy Authority, Cairo, Egypt. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 90 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Among the important key modulators of the tumor microenvironment and hypoxia is a family of enzymes named carbonic anhydrases. Herein, 11 novel sulfonamide-pyridine hybrids (2-12) were designed, synthesized and biologically evaluated for their potential use in targeting breast cancer. Methods & results: The para chloro derivative 7 reported the highest cytotoxic activity against the three breast cancer cell lines used. In addition, compound 7 was found to induce cell cycle arrest and autophagy as well as delaying wound healing. The IC50 of compound 7 against carbonic anhydrase IX was 253 ± 12 nM using dorzolamide HCl as control.

Conclusion

This study encourages us to expand the designed library, where more sulfonamide derivatives would be synthesized and studied for their structure-activity relationships.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFemaleHumansAntigens, NeoplasmApoptosisCarbonic Anhydrase InhibitorsCarbonic Anhydrase IXMolecular StructurePyridinesStructure-Activity RelationshipSulfonamidesTumor Microenvironment

Stichwörter der Autor:innen

apoptosisbreast cancercarbonic anhydrasehypoxiasulfonamides

Substanzen

Antigens, NeoplasmCarbonic Anhydrase InhibitorsCarbonic Anhydrase IXPyridinesSulfonamides

Autor:innen und Institutionen

  • Drug Radiation Research, National Center for Radiation Research & Technology (NCRRT), Egyptian Atomic Energy Authority, Cairo, Egypt.
  • Pharmaceutical Research Department, Nawah Scientific, Cairo, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The British University in Egypt (BUE), El-Sherouk City, Cairo, 11837, Egypt.
  • The Center for Drug Research & Development (CDRD), Faculty of Pharmacy, The British University in Egypt (BUE), El-Sherouk City, Cairo, 11837, Egypt.

ORCID-Profile: Nashwa H Zaher

Zitieren

APA

Zaher, N. H., Elhazek, R. M., Gouda, A. E., Khalil, A., & Elgazzar, M. G. (2023). Challenging Breast Cancer Through Novel sulfonamide–pyridine Hybrids: design, synthesis, Carbonic Anhydrase IX Inhibition and Induction of Apoptosis. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2022-0197

Vancouver

Zaher NH, Elhazek RM, Gouda AE, Khalil A, Elgazzar MG. Challenging Breast Cancer Through Novel sulfonamide–pyridine Hybrids: design, synthesis, Carbonic Anhydrase IX Inhibition and Induction of Apoptosis. Future Medicinal Chemistry. 2023. doi:10.4155/fmc-2022-0197

BibTeX
@article{Zaher2023,
  author = {Zaher, Nashwa H and Elhazek, Reham Mm and Gouda, Ahmed E and Khalil, Amira and Elgazzar, Marwa G},
  title = {Challenging Breast Cancer Through Novel sulfonamide–pyridine Hybrids: design, synthesis, Carbonic Anhydrase IX Inhibition and Induction of Apoptosis},
  journal = {Future Medicinal Chemistry},
  year = {2023},
  doi = {10.4155/fmc-2022-0197}
}
Kostenlos starten →